Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cell Therapy for Craniofacial Bone Defects
NCT01616953Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Aug 2012
- Primary completion
- Jun 2015
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ixmyelocel-T, sponsored by University of Michigan. Started Aug 2012; status: completed.
02
Drugs
ixmyelocel-T
Beyond the preview
Go deeper on NCT01616953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616953.